PTN
Palatin Technologies, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.21M
P/E Ratio
123.68
EPS
$0.11
Beta
-0.11
52W High
$31.00
52W Low
$5.00
50-Day MA
$17.59
200-Day MA
$15.57
Dividend Yield
—
Profit Margin
-48.50%
Forward P/E
42.92
PEG Ratio
1.62
About Palatin Technologies, Inc. Common Stock
Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.
Fundamentals
| Revenue (TTM) | $12.88M |
| Gross Profit (TTM) | 551,400 |
| EBITDA | $-8.75M |
| Operating Margin | -40.30% |
| Return on Equity | -297.20% |
| Return on Assets | -65.30% |
| Revenue/Share (TTM) | $6.28 |
| Book Value | $5.96 |
| Price-to-Book | 2.29 |
| Price-to-Sales (TTM) | 1.88 |
| EV/Revenue | 1.113 |
| EV/EBITDA | 0.55 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -80.10% |
| Shares Outstanding | $1.78M |
| Float | $1.38M |
| % Insiders | 1.08% |
| % Institutions | 55.58% |
Historical Volatility
HV 10-Day
54.11%
HV 20-Day
56.10%
HV 30-Day
75.52%
HV 60-Day
76.02%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($53.50 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026